Bio-Techne
TECH
$79.39
Share price
-1.73%
Change (1 day)
-4.92%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - Total assets
Total assets on the balance sheet as of March 2024 : $2.72 B
According to Bio-Techne's latest financial reports the company's total assets are $2.72 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bio-Techne - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | $2.63 B | 14.99% |
| 2022-06-30 | $2.29 B | 1.41% |
| 2021-06-30 | $2.26 B | 11.61% |
| 2020-06-30 | $2.02 B | 7.6% |
| 2019-06-30 | $1.88 B | 18.28% |
| 2018-06-30 | $1.59 B | 2.25% |
| 2017-06-30 | $1.55 B | 37.95% |
| 2016-06-30 | $1.12 B | 6.23% |
| 2015-06-30 | $1.06 B | 23.29% |
| 2014-06-30 | $0.86 B | 10.85% |
| 2013-06-30 | $0.77 B | 8.17% |
| 2012-06-30 | $0.71 B | 16.46% |
| 2011-06-30 | $0.61 B | 19.05% |
| 2010-06-30 | $0.51 B | 9.92% |
| 2009-06-30 | $0.47 B | -6.97% |
| 2008-06-30 | $0.50 B | 11.55% |
| 2007-06-30 | $0.45 B | 22.76% |
| 2006-06-30 | $0.37 B | 25.49% |
| 2005-06-30 | $0.29 B | -9.28% |
| 2004-06-30 | $0.32 B | 23.62% |
| 2003-06-30 | $0.26 B | 10.51% |
| 2002-06-30 | $0.23 B | 10.54% |
| 2001-06-30 | $0.21 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $97.09 B | 3,468.13% | 🇺🇸 USA |
 Becton Dickinson BDX | $54.15 B | 1,890.21% | 🇺🇸 USA |
 General Electric GE | $163.94 B | 5,924.69% | 🇺🇸 USA |
 Danaher DHR | $83.40 B | 2,964.93% | 🇺🇸 USA |
 Qiagen QGEN | $5.80 B | 113.36% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $99.07 M | -96.36% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $12.60 B | 363.40% | 🇺🇸 USA |